DICE Therapeutics, Inc. - Common Stock (NQ:DICE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 8, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DICE Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

DICE Announces Proposed Public Offering of Common Stock

October 11, 2022

From DICE Therapeutics, Inc.

Via GlobeNewswire

Nasdaq Drops 150 Points; AZZ Shares Plummet ↗

October 11, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 11, 2022

Gainers

Via Benzinga

Dow Surges Over 100 Points; Crude Oil Down 2% ↗

October 11, 2022

U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday.

Via Benzinga

What Is Going on With DICE Therapeutics (DICE) Stock? ↗

October 11, 2022

Shares of DICE stock are up an astounding 50% today on news of a positive clinical trial related to the Dice's psoriasis treatment.

Via InvestorPlace

DICE Therapeutics Stock Doubles After Positive Data From Lead Psoriasis Candidate ↗

October 11, 2022

Via Benzinga

HC Wainwright Is Bullish On DICE Therapeutics - Read Why ↗

July 18, 2022

Via Benzinga

Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

October 11, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.

Via Benzinga

DICE Therapeutics, Amgen And Some Other Big Stocks Moving Higher On Tuesday ↗

October 11, 2022

U.S. stocks traded mostly lower, with the Nasdaq dropping more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

US Stocks Open Lower, Dow Falls 100 Points ↗

October 11, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.

Via Benzinga

Analyzing DICE Therapeutics's Short Interest ↗

October 11, 2022

DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 5.55% since its last report. The company recently reported that it has 4.93 million shares sold short, which is 17.52% of all regular...

Via Benzinga

Nasdaq Bear Market: 2 Stocks Defying the Downturn ↗

October 11, 2022

One of these companies is a leader in its niche, while the other wants to become one.

Via The Motley Fool

Dice Therapeutics Surges To Record High As Psoriasis Pill Promises To Lead Its Class ↗

October 11, 2022

The company is testing a potential pill to treat psoriasis.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 11, 2022

Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.

Via Benzinga

DICE Therapeutics Announces Positive Topline Data from Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for Psoriasis

October 11, 2022

From DICE Therapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 22, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Looking Into DICE Therapeutics's Recent Short Interest ↗

September 13, 2022

DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 7.8% since its last report. The company recently reported that it has 5.22 million shares sold short, which...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 12, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 ↗

September 14, 2022

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...

Via Benzinga

Dow Up Over 280 Points, Fourth-Straight Win In Sight ↗

September 12, 2022

Stocks are firmly higher midday, with the Dow Jones Industrial Average last seen up over 280 points, while both the S&P 500 Index and Nasdaq Composite boast sizable gains of their own.

Via Talk Markets

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday ↗

September 12, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

US Stocks Open Higher, Nasdaq Surges Over 100 Points ↗

September 12, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 02, 2021

Gainers Biofrontera (NASDAQ:BFRI) shares ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA

Via Benzinga

48 Biggest Movers From Yesterday ↗

October 21, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 ↗

October 11, 2021

Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.